…
CYIOS Corporation operates as a holding company that engages in building, acquiring, and operating businesses across medical supplies, technology, and fintech industries. The company, through its subsidiary, delivers products to healthcare providers. CYIOS Corporation was founded in 1997 and is based in Deerfield Beach, Florida.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Publicly available information on CYIOS Corporation (ticker CYIO on the Pink Sheets) is limited; the company is an OTC-listed small-cap with minimal current disclosure and its precise core business and operations are not well documented. Long-term growth depends on clarifying the business model, securing financing or strategic partners and executing any stated plans; investors may find potential upside if transparency and operational traction improve.
Key risks include limited disclosure and liquidity, substantial financing needs, execution and governance uncertainty, and heightened risk of regulatory action or delisting.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Income before tax | -1.31M | -0.27M | -2.38M | -2.89M | -0.74M |
| Net income | -1.31M | -0.36M | -2.38M | -2.89M | -0.74M |
| Gross profit | 0.53M | 0.04M | 0.06M | -0.03M | 0.01M |
| Ebit | - | 0.13M | -1.55M | -1.12M | -0.72M |
| Ebitda | -0.91M | 0.13M | -1.32M | -1.12M | -0.52M |
| Depreciation and amortization | - | 0.00M | 0.23M | 0.00M | 0.21M |
| Operating income | -0.19M | -0.46M | -1.08M | -1.20M | -0.72M |
| Other operating expenses | 8.21M | 0.49M | 1.18M | 1.94M | 0.76M |
| Interest expense | 0.40M | 0.40M | 0.83M | 1.77M | 0.01M |
| Income tax expense | - | -0.00M | -0.23M | 0.00M | -0.21M |
| Total revenue | 8.02M | 0.04M | 0.10M | 0.74M | 0.04M |
| Total operating expenses | 0.73M | 0.49M | 1.14M | 1.16M | 0.74M |
| Cost of revenue | 7.49M | 0.00M | 0.04M | 0.78M | 0.03M |
| Total other income expense net | -1.11M | 0.09M | -1.30M | -1.69M | -0.01M |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Total assets | 0.96M | 1.02M | 1.05M | 1.57M | 0.06M |
| Other current assets | 0.07M | 0.03M | 0.07M | 0.11M | - |
| Total liab | 2.99M | 2.53M | 2.51M | 1.68M | 0.59M |
| Total stockholder equity | -2.03M | -1.51M | -1.46M | -0.11M | -0.53M |
| Other current liab | -0.00M | 0.00M | 0.01M | 0.01M | - |
| Common stock | 0.28M | 0.24M | 0.15M | 0.12M | 0.09M |
| Retained earnings | -32.44M | -31.23M | -30.86M | -28.48M | -25.60M |
| Good will | 0.25M | 0.93M | 0.93M | 0.68M | - |
| Other assets | - | 0.00M | - | - | - |
| Cash | 0.03M | 0.01M | 0.00M | 0.34M | 0.04M |
| Total current liabilities | 2.99M | 2.53M | 2.51M | 1.68M | 0.18M |
| Current deferred revenue | - | - | - | 0.00M | - |
| Net debt | 2.33M | 2.01M | 2.09M | 1.26M | 0.37M |
| Short term debt | 2.36M | 2.02M | 2.09M | 1.60M | 0.00M |
| Short long term debt total | 2.36M | 2.02M | 2.09M | 1.60M | 0.41M |
| Other stockholder equity | 29.91M | 29.47M | 28.56M | 27.32M | 24.79M |
| Total current assets | 0.61M | 0.05M | 0.08M | 0.46M | 0.06M |
| Net receivables | 0.43M | - | - | 0.00M | - |
| Inventory | 0.09M | 0.01M | 0.01M | 0.01M | 0.02M |
| Accounts payable | 0.62M | 0.51M | 0.41M | 0.07M | 0.18M |
| Accumulated other comprehensive income | 0.23M | 0.01M | 0.68M | 0.91M | 0.19M |
| Non currrent assets other | - | -0.00M | - | 0.38M | - |
| Non current assets total | 0.35M | 0.97M | 0.97M | 1.11M | - |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Total cashflows from investing activities | - | 0.00M | 0.01M | -0.15M | 0.01M |
| Total cash from financing activities | 0.32M | 0.07M | 0.50M | 1.37M | 0.60M |
| Net income | -1.31M | -0.27M | -2.38M | -0.34M | -0.74M |
| Change in cash | 0.02M | 0.01M | -0.34M | 0.30M | 0.04M |
| Begin period cash flow | 0.01M | 0.00M | 0.34M | 0.04M | - |
| End period cash flow | 0.03M | 0.01M | 0.00M | 0.34M | 0.04M |
| Total cash from operating activities | -0.30M | -0.06M | -0.85M | -0.92M | -0.58M |
| Depreciation | - | 0.00M | - | 0.00M | - |
| Other cashflows from investing activities | - | -0.00M | - | -0.10M | 0.01M |
| Change to inventory | -0.03M | - | - | 0.01M | -0.02M |
| Change to account receivables | 0.23M | - | 0.00M | -0.00M | - |
| Other cashflows from financing activities | - | 0.07M | 0.50M | 0.00M | 0.19M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Change in working capital | 0.17M | 0.14M | 0.38M | -0.20M | 0.16M |
| Other non cash items | 0.84M | 0.07M | 1.16M | -0.38M | -0.16M |
| Free cash flow | -0.30M | -0.06M | -0.85M | -0.92M | -0.58M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CYIO CYIOS Corporation |
- -% |
0.00 | - | - | 0.39 | 1.52 | 1.76 | -45.74 |
| HCA HCA Healthcare, Inc. |
15.19 3.30% |
475.52 | 14.27 | 13.46 | 1.21 | 291.34 | 1.83 | 8.99 |
| THC Tenet Healthcare Corporation |
-0.10 0.04% |
263.49 | 10.08 | 12.66 | 0.96 | 4.57 | 1.43 | 5.80 |
| FSNUY Fresenius SE & Co KGaA ADR |
-0.22 1.52% |
14.00 | 16.87 | 9.44 | 0.42 | 0.78 | 0.79 | 5.37 |
| JDHIY JD Health International Inc |
1.31 30.75% |
5.57 | 62.50 | 35.97 | 0.30 | 2.32 | 0.16 | 3.90 |
CYIOS Corporation operates as a holding company that engages in building, acquiring, and operating businesses across medical supplies, technology, and fintech industries. The company, through its subsidiary, delivers products to healthcare providers. CYIOS Corporation was founded in 1997 and is based in Deerfield Beach, Florida.
258 South Military Trail, Deerfield Beach, FL, United States, 33442
888 285 1351
15
| Name | Title | Year Born |
|---|---|---|
| Mr. David Lewis | CEO & Director | NA |
| Mr. Franco Devivo | VP Marketing & Bus. Devel. | NA |
| Mr. John Fredrick O'Shea | CEO & Chairman of the Board | 1968 |
| Mr. Jonathan D. Leinwand Esq. | Legal council | 1970 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.